Cargando…
PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045379/ http://dx.doi.org/10.1186/1546-0096-11-S2-O15 |
| _version_ | 1782319310184644608 |
|---|---|
| author | De Benedetti, F Ruperto, N Zuber, Z Cuttica, R Xavier, R Calvo, I Rubio, N Alekseeva, E Chasnyk, V Chavez, J Horneff, G Opoka-Winiarska, V Quartier, P Spindler, A Keane, C Bharucha, K Wang, J Lovell, D Martini, A Brunner, HI |
| author_facet | De Benedetti, F Ruperto, N Zuber, Z Cuttica, R Xavier, R Calvo, I Rubio, N Alekseeva, E Chasnyk, V Chavez, J Horneff, G Opoka-Winiarska, V Quartier, P Spindler, A Keane, C Bharucha, K Wang, J Lovell, D Martini, A Brunner, HI |
| author_sort | De Benedetti, F |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4045379 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40453792014-06-20 PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH De Benedetti, F Ruperto, N Zuber, Z Cuttica, R Xavier, R Calvo, I Rubio, N Alekseeva, E Chasnyk, V Chavez, J Horneff, G Opoka-Winiarska, V Quartier, P Spindler, A Keane, C Bharucha, K Wang, J Lovell, D Martini, A Brunner, HI Pediatr Rheumatol Online J Oral Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4045379/ http://dx.doi.org/10.1186/1546-0096-11-S2-O15 Text en Copyright © 2013 De Benedetti et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation De Benedetti, F Ruperto, N Zuber, Z Cuttica, R Xavier, R Calvo, I Rubio, N Alekseeva, E Chasnyk, V Chavez, J Horneff, G Opoka-Winiarska, V Quartier, P Spindler, A Keane, C Bharucha, K Wang, J Lovell, D Martini, A Brunner, HI PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH |
| title | PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH |
| title_full | PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH |
| title_fullStr | PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH |
| title_full_unstemmed | PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH |
| title_short | PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH |
| title_sort | pres-final-2180: efficacy and safety of tocilizumab (tcz) in patients with polyarticular-course juvenile idiopathic arthritis (pcjia): 2-year data from cherish |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045379/ http://dx.doi.org/10.1186/1546-0096-11-S2-O15 |
| work_keys_str_mv | AT debenedettif presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT ruperton presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT zuberz presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT cutticar presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT xavierr presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT calvoi presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT rubion presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT alekseevae presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT chasnykv presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT chavezj presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT horneffg presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT opokawiniarskav presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT quartierp presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT spindlera presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT keanec presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT bharuchak presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT wangj presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT lovelld presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT martinia presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish AT brunnerhi presfinal2180efficacyandsafetyoftocilizumabtczinpatientswithpolyarticularcoursejuvenileidiopathicarthritispcjia2yeardatafromcherish |